Chemokines: Role in immune cell traffic

European Cytokine Network

Volumn 14, Issue 4, 2003, Pages 204-210

  Moser, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

B LYMPHOCYTE; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MOTILITY; MACROPHAGE; METASTASIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CHEMOKINES; HUMANS; IMMUNE SYSTEM; LEUKOCYTES; RECEPTORS, CHEMOKINE;

EID: 1642579716     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55: 97.
2. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu. Rev. Immunol. 15: 675-705.
3. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145.
4. Murphy PM. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54: 227.
5. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121.
6. Loetscher P, Moser B, Baggiolini M. 2000. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol 74: 127.
7. Thelen M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2: 129.
8. Moser B, Loetscher M, Piali L, Loetscher P. 1998. Lymphocyte responses to chemokines. Intern. Rev. Immunol. 16: 323.
9. Moser B, Schumacher C, von Tscharner V, Clark-Lewis I, Baggiolini M. 1991. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J. Biol. Chem. 266: 10666.
10. Schnitzel W, Garbeis B, Monschein U, Besemer J. 1991. Neutrophil activating peptide-2 binds with two affinities to receptor(s) on human neutrophils. Biochem. Biophys. Res. Commun. 180: 301.
11. Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253: 1278.
12. Murphy PM, Tiffany HL. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253: 1280.
13. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell. Biol. 3: 639-50.
14. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. 2001. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22: 328.
15. D'Amico G, Frascaroli G, Bianchi G, Transidico P, Doni A, Vecchi A, Sozzani S, Allavena P, Mantovani A. 2000. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. I: 387.
16. Lindley I, Westwick J, Kunkel SL. 1993. Nomenclature announcement - the chemokines. Immunol. Today 14: 24.
17. Moser B, Loetscher P. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123.
18. Laudanna C, Kim JY, Constantin G, Butcher E. 2002. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186: 37.
19. Nagasawa T. 2000. A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis. Int. J. Hematol. 72: 408.
20. Annunziato F, Romagnani P, Cosmi L, Lazzeri E, Romagnani S. 2001. Chemokines and lymphopoiesis in human thymus. Trends Immunol. 22: 277.
21. Savino W, Mendes-da-Cruz DA, Silva JS, Dardenne M, Cotta-de-Almeida V 2002. Intrathymic T-cell migration: a combinatorial interplay of extracellular matrix and chemokines ? Trends Immunol. 23: 305.
22. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50.
23. Murphy PM. 2001. Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345: 833.
24. Gerard C, Rollins BJ. 2001. Chemokines and disease. Nat. Immunol. 2: 108.
25. Luther SA, Cyster JG. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2: 102-107.
26. Murphy PM. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2: 116.
27. Yoshie O, Imai T, Nomiyama H. 2001. Chemokines in immunity. Adv. Immunol. 78: 57.
28. Sallusto F, Lanzavecchia A. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177: 134-140.
29. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A. 2000. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 177: 141.
30. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410: 101.
31. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413.
32. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. 1999. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72: 209.
33. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286: 2098.
34. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553.
35. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Forster R. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192: 1545.
36. Moser B, Schaerli P, Loetscher P. 2002. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol 23: 250.
37. Kaech SM, Wherry EJ, Ahmed R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251.
38. Lanzavecchia A, Sallusto F. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92.
39. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708.
40. Lanzavecchia A, Sallusto F. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2: 982.
41. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, Von Andrian UH, Ahmed R. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225.
42. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC 2001. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108: 1331.
43. Onuffer JJ, Horuk R. 2002. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci 23: 459.
44. Proudfoot AE. 2002. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2: 106.
45. Clark-Lewis I, Kim K-S, Rajarathnam K, Gong J-H, Dewald B, Moser B, Baggiolini M, Sykes BD. 1995. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57: 703.
46. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. Embo. J. 16: 6996.
47. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E, Norcross MA. 1997. Regulation of the receptor specificity and function of the chemokine Rantes (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186: 1865.
48. De Meester I, Korom S, Van Damme J, Scharpé S. 1999. CD26, let it cut or cut it down. Immunol. Today 20: 367.
49. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. 2002. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100: 1160.
50. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3: 687.
51. Wolf M, Clark-Lewis I, Buri C, Langen H, Lis M, Mazzucchelli L. 2003. Cathepsin D Specifically Cleaves the Chemokines Macrophage Inflammatory Protein-1alpha, Macrophage Inflammatory Protein-1beta, and SLC That Are Expressed in Human Breast Cancer. Am. J. Pathol. 162: 1183.
52. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I. 2001. The ligands of CXC chemokine receptor 3, ITAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 276: 2986.
53. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M. 2001. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97: 1920.
54. Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M. 1999. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94: 1899.